In order to further help promote acupuncture and moxibustion technology and promote the inheritance, innovation and development of traditional Chinese medicine, four recommended national standards in the field of acupuncture and moxibustion, including the “Acupoint Medication Specification” proposed by the State Administration of Traditional Chinese Medicine and approved and issued by the General Administration of Market Regulation, were implemented on October 1. The “Acupoint Acupoint Medication Specification” regulates the use of acupoint acupoint medication, enhances drug safety, refines technical operation, increases acupoint coverage area requirements, scientifically defines indications, and provides technical specifications that can be directly referenced for primary clinical practice. “Handling Abnormal Acupuncture Situations” clarifies scientific treatment methods for 11 types of common abnormalities such as needle fainting, needle retention, acupuncture pneumothorax, and burns, and strengthens risk prevention and control throughout the acupuncture and moxibustion diagnosis and treatment process. The “Acupuncture and Moxibustion Technique Operation Specification Part 4: Triangular Needle” system regulates the core content of triangular acupuncture therapy, such as conceptual definitions, operation procedures, and contraindications, and establishes uniform standards for the four types of technical operations: pricking method, pricking method, and treatment method. The “Acupuncture and Moxibustion Technique Operation Specification Part 6: Acupoint Injection” regulates the concepts, operating procedures and requirements, precautions, contraindications, etc. of acupuncture therapy, and provides general guidelines for clinical, teaching and scientific research fields.

In order to further help promote acupuncture and moxibustion technology and promote the inheritance, innovation and development of traditional Chinese medicine, four recommended national standards in the field of acupuncture and moxibustion, including the “Acupoint Medication Specification” proposed by the State Administration of Traditional Chinese Medicine and approved and issued by the General Administration of Market Regulation, were implemented on October 1. The “Acupoint Acupoint Medication Specification” regulates the use of acupoint acupoint medication, enhances drug safety, refines technical operation, increases acupoint coverage area requirements, scientifically defines indications, and provides technical specifications that can be directly referenced for primary clinical practice. “Handling Abnormal Acupuncture Situations” clarifies scientific treatment methods for 11 types of common abnormalities such as needle fainting, needle retention, acupuncture pneumothorax, and burns, and strengthens risk prevention and control throughout the acupuncture and moxibustion diagnosis and treatment process. The “Acupuncture and Moxibustion Technique Operation Specification Part 4: Triangular Needle” system regulates the core content of triangular acupuncture therapy, such as conceptual definitions, operation procedures, and contraindications, and establishes uniform standards for the four types of technical operations: pricking method, pricking method, and treatment method. The “Acupuncture and Moxibustion Technique Operation Specification Part 6: Acupoint Injection” regulates the concepts, operating procedures and requirements, precautions, contraindications, etc. of acupuncture therapy, and provides general guidelines for clinical, teaching and scientific research fields.